Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Palomar Medical Technologies/Coherent

This article was originally published in The Gray Sheet

Executive Summary

Palomar Medical Technologies/Coherent: Ink definitive agreement under which Coherent gains exclusive distribution rights to Palomar's EpiLaser laser-based hair removal systems in the U.S., Far East and "most countries in Europe," Palomar says. Under terms of the agreement, Coherent pays $3.5 mil. up front for the distribution rights, "a license to key patents relating to hair removal," and a three-year warrant to purchase shares of Palomar common stock with an exercise price of $5.25 per share. Coherent, with 200 direct sales reps, will be responsible for sales, marketing, service, training and education under the deal, for which the two companies signed a letter of intent in September ("The Gray Sheet" Nov. 3, p. 11)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009196

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel